DE60126349D1 - Rekombinantes nukleoprotein von newcastle-krankheitsvirus als markierungsimpfstoff - Google Patents

Rekombinantes nukleoprotein von newcastle-krankheitsvirus als markierungsimpfstoff

Info

Publication number
DE60126349D1
DE60126349D1 DE60126349T DE60126349T DE60126349D1 DE 60126349 D1 DE60126349 D1 DE 60126349D1 DE 60126349 T DE60126349 T DE 60126349T DE 60126349 T DE60126349 T DE 60126349T DE 60126349 D1 DE60126349 D1 DE 60126349D1
Authority
DE
Germany
Prior art keywords
vaccine
marking
disease virus
newcastle disease
recombinant nucleoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126349T
Other languages
English (en)
Other versions
DE60126349T2 (de
Inventor
Teshome Mebatsion
Marcus Josephus Marie Koolen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Application granted granted Critical
Publication of DE60126349D1 publication Critical patent/DE60126349D1/de
Publication of DE60126349T2 publication Critical patent/DE60126349T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60126349T 2000-11-02 2001-10-30 Rekombinantes nukleoprotein von newcastle-krankheitsvirus als markierungsimpfstoff Expired - Lifetime DE60126349T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00203814 2000-11-02
EP00203814 2000-11-02
PCT/EP2001/012573 WO2002036617A2 (en) 2000-11-02 2001-10-30 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine

Publications (2)

Publication Number Publication Date
DE60126349D1 true DE60126349D1 (de) 2007-03-15
DE60126349T2 DE60126349T2 (de) 2007-05-31

Family

ID=8172212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126349T Expired - Lifetime DE60126349T2 (de) 2000-11-02 2001-10-30 Rekombinantes nukleoprotein von newcastle-krankheitsvirus als markierungsimpfstoff

Country Status (15)

Country Link
US (1) US7070789B2 (de)
EP (1) EP1383795B1 (de)
JP (2) JP4476543B2 (de)
AT (1) ATE352557T1 (de)
AU (2) AU2481502A (de)
CA (1) CA2427578C (de)
CY (1) CY1106493T1 (de)
DE (1) DE60126349T2 (de)
DK (1) DK1383795T3 (de)
ES (1) ES2278810T3 (de)
HU (1) HU226256B1 (de)
MX (1) MXPA03003700A (de)
PL (1) PL207132B1 (de)
PT (1) PT1383795E (de)
WO (1) WO2002036617A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines
US7473884B2 (en) 2005-04-21 2009-01-06 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. Orientation determination utilizing a cordless device
CN1293195C (zh) * 2005-09-02 2007-01-03 中国农业科学院哈尔滨兽医研究所 新城疫LaSota疫苗株反向遗传操作系统及其应用
CN1298845C (zh) * 2005-09-02 2007-02-07 中国农业科学院哈尔滨兽医研究所 表达禽流感病毒H5亚型HA蛋白的重组新城疫LaSota弱毒疫苗株
TWI531652B (zh) 2005-12-02 2016-05-01 美國紐約大學西奈山醫學院 表現非原生表面蛋白質之嵌合病毒及其用途
WO2007104782A1 (en) * 2006-03-15 2007-09-20 Intervet International B.V. Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus
KR20080103602A (ko) 2006-03-15 2008-11-27 인터벳 인터내셔널 비.브이. 재조합 모노네가바이랄러스 바이러스 벡터
US7796119B2 (en) 2006-04-03 2010-09-14 Avago Technologies General Ip (Singapore) Pte. Ltd. Position determination with reference
US20080008736A1 (en) * 2006-07-06 2008-01-10 Thierry Glauser Random copolymers of methacrylates and acrylates
KR100801180B1 (ko) 2006-09-26 2008-02-05 주식회사 고려비엔피 약독화된 재조합 뉴캐슬병 바이러스 및 이를 함유하는뉴캐슬병 백신
CN101802173B (zh) * 2007-06-13 2014-09-24 联邦科学技术研究组织 调节禽类的生产性状
EP2085092A1 (de) 2008-01-29 2009-08-05 Bayer Schering Pharma Aktiengesellschaft Abgeschwächte onkolytische Paramyxoviren zur Kodierung von Vogel-Zytokinen
US20090246226A1 (en) * 2008-03-28 2009-10-01 Zeon Corporation Avian vaccines possessing a positive marker gene
CA2736799A1 (en) * 2008-08-25 2010-03-11 Burnham Institute For Medical Research Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
RU2016112465A (ru) * 2009-08-21 2018-11-27 Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. Рекомбинантная вакцина на основе парамиксовирусов птиц и способ её приготовления и применения
ES2380289T3 (es) 2009-11-30 2012-05-10 United Cancer Research Institute Nuevo clon del virus de la enfermedad de Newcastle, su fabricación y aplicación en el tratamiento médico del cáncer
AR079767A1 (es) * 2009-12-28 2012-02-15 Merial Ltd Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo
CN107630008B (zh) * 2016-07-14 2021-01-26 中国农业大学 基因ⅶ型新城疫病毒标记疫苗株及其应用
CN108956986B (zh) * 2018-05-24 2021-07-02 苏州优迪生物科技有限公司 新城疫病毒抗体检测试剂盒
CN112111467B (zh) * 2020-09-27 2021-06-22 湖北省农业科学院畜牧兽医研究所 一种基因vii型新城疫标记疫苗株及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0974660A1 (de) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
US6146642A (en) * 1998-09-14 2000-11-14 Mount Sinai School Of Medicine, Of The City University Of New York Recombinant new castle disease virus RNA expression systems and vaccines

Also Published As

Publication number Publication date
WO2002036617A2 (en) 2002-05-10
JP2004517612A (ja) 2004-06-17
DE60126349T2 (de) 2007-05-31
PL207132B1 (pl) 2010-11-30
AU2002224815B2 (en) 2006-10-12
ES2278810T3 (es) 2007-08-16
EP1383795B1 (de) 2007-01-24
ATE352557T1 (de) 2007-02-15
HU226256B1 (en) 2008-07-28
US7070789B2 (en) 2006-07-04
CY1106493T1 (el) 2012-01-25
HUP0302265A2 (hu) 2003-10-28
PT1383795E (pt) 2007-04-30
PL365987A1 (en) 2005-01-24
JP4476543B2 (ja) 2010-06-09
WO2002036617A3 (en) 2003-10-23
JP2010145412A (ja) 2010-07-01
MXPA03003700A (es) 2004-05-04
US20040043035A1 (en) 2004-03-04
CA2427578A1 (en) 2002-05-10
EP1383795A2 (de) 2004-01-28
CA2427578C (en) 2011-09-06
AU2481502A (en) 2002-05-15
DK1383795T3 (da) 2007-05-29
HUP0302265A3 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
DE60126349D1 (de) Rekombinantes nukleoprotein von newcastle-krankheitsvirus als markierungsimpfstoff
DK0677114T3 (da) Rekombinant svinekoppevirus
ATE376059T1 (de) Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
NZ595736A (en) Chimeric viruses presenting non-native surface proteins and uses thereof
CY1108930T1 (el) Συνθεση εμβολιου της γριπης
UA84254C2 (ru) МИНИМАЛЬНАЯ ПЛАЗМИДНАЯ СИСТЕМА ДЛЯ ГЕНЕРИРОВАНИЯ ИНФЕКЦИОННЫХ МИНУС-ЦЕПОЧЕЧНЫХ РНК ВИРУСОВ С КЛОНИРОВАННОЙ ВИРУСНОЙ кДНК, КЛЕТКА-ХОЗЯИН, КОТОРАЯ ВКЛЮЧАЕТ ПЛАЗМИДНУЮ СИСТЕМУ, СПОСОБ ПРОДУЦИРОВАНИЯ ИНФЕКЦИОННОГО МИНУС-ЦЕПОЧЕЧНОГО РНК ВИРУСА И СПОСОБ ПРИВИВКИ СУБЪЕКТА ОТ ИНФЕКЦИИ МИНУС-ЦЕПОЧЕЧНОГО РНК ВИРУСА
ATE320493T1 (de) Modifizierung des hepatitis b kernantigens
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
CY1106635T1 (el) Ανοσοενισχυτικο που περιεχει ν - φορμυλο μεθειονυλο-πεπτιδια για εμβολια
ECSP045300A (es) Antígenos virales
MX9207113A (es) Fragmento de adn, peptido que comprende una proteina superficial ha de un virus de gripe a y vacuna que comprende tal peptido.
ATE267211T1 (de) Impfstoff gegen hpv
ES2135406T3 (es) Virosomas de la influenza reconstituidos inmunoestimulantes e inmunopotencializadores y vacunas que los contienen.
DE69333814D1 (de) Genetischer impfstoff gegen den immunschwäche virus
DK2251419T3 (da) Porcint reproduktions- og respirations-syndrom-vaccine baseret på isolat JA-142
EA200300129A1 (ru) Очистка антигенов вируса гепатита b (hbv) для применения в вакцинах
AR056133A1 (es) Virus de influenza canina y composiciones relacionadas y metodos de uso
EA200000528A1 (ru) Способ получения вакцин для предупреждения патогенных эффектов, связанных с ретровирусной инфекцией
BR0312474A (pt) Partìcula viral adjuvante
ATE399210T1 (de) Knockout-mutante von vaccinia-virus und verwendung davon
AR057225A1 (es) Vacunas marcadas contra el virus de la diarrea virica bovina
Strohmeier et al. A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
DE69818913D1 (de) Rekombinanter Birnavirusimpfstoff
ATE544865T1 (de) Assays für den zusammenbau von ebola-virus- nukleocapsiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition